C71T
CANCELLED SECTION 71
05/15/2026
Back to search
Official data from USPTO
INNOPHLEX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
INNOPHLEX
ST13
US500000079236788Class
35, 42, 44
Filing
79236788
Registration
5893636
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
06/09/2026
Trademark type
Word
Nice classes
35, 42, 44
Filing date
01/12/2018
Registration date
10/29/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/15/2026
Last transaction
06/09/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
Friedrichsdorf, DE
Examiner
PODESTA, GIDETTE
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
PharmaLex GmbH
Representatives
Mark J. Liss Leydig, Voit & Mayer Ltd.
Technical classification
Nice Classes
Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Advertising servicesbusiness management for otherscompany administration in the nature of business administration services; providing office functions; business efficiency expert services; systemization of information into computer databases; compilation of information into computer databases; business assistance and consultancy in the context of the retailing and wholesaling of medicines; providing of outsourcing services in the field of business management for companies engaged in the field of medicine authorizationproductionsalesafety and monitoring; regulatory submission managementfiling of documents for authorizing medicines using documentsreports and files required by regulatory authorities; administrative assistance and consultancy in the nature of preparation and filing of applications for pharmaceutical medicine approval with governmental regulatory bodies
Class 42
Scientific and technological services and research and design relating theretoscientific researchlaboratory research in the field of pharmaceuticals; industrial analysis and research serviceslaboratory research services relating to pharmaceuticalspharmaceutical research services; research and development of new products for others; provision of surveysmedical research surveys; software development servicesdevelopment of a web application for inputting and using informative texts for medicines and medical productsin particular user guidespackaging insertsspecialist informationfor providing various documents; database serviceselectronic storage of data in computer databases; conversion of data or documents from physical to electronic media; research in relation to scientific work; preparation of scientific analysis and assessments; pharmaceutical product evaluation; consultancy pertaining to pharmacology; consultancy relating to research and development in the field of therapeutics; consultancy relating to laboratory testing; pharmaceutical products development; development of pharmaceutical preparations and medicines; testing of pharmaceuticals; provision of information and data relating to medical and veterinary research and development; inspection of pharmaceuticals; scientific investigations for medical purposes; conducting early evaluations in the field of new pharmaceuticals; pharmaceutical drug development services; medical laboratory services; information technology advisoryconsultancy and information services for the pharmaceutical and healthcare industries; scientific assessment of the efficiency of medicines; services for assessing the efficiency of pharmaceuticals being pharmaceutical product evaluation; analysis and evaluation of product design; analysis and evaluation of product development; quality control testing for others; materials testing and evaluation; product safety testing; quality control servicestestinganalysis and evaluation of the services of others to determine conformity with certification standards; quality testing of products for certification purposes; assistance and consultancy in the nature of pharmaceutical research in the field of medicine safety and monitoring; pharmaceutical drug development consultancy in the field of medicine safety
Class 44
Providing pharmaceutical and medical assistance and consultancy during an initial application process of marketing authorization or product approval for pharmaceutical companies; provision of medical and pharmaceutical advice and expertise for pharmaceutical companies; providing information relating to the preparation and dispensing of medications; provision of pharmaceutical information; provision of information relating to medicine; consultancy and information services provided via the internet relating to pharmaceutical products; consultancy and information services relating to pharmaceutical products; consultancy and information services relating to biopharmaceutical products; advisory services relating to pharmaceuticals; medical servicesmedical diagnostic services; medical servicesmedical diagnostic services and pharmaceutical advisory services and consultancy in the field of medicine safety
Publications
History of USPTO decisions and trademark events.
38 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/15/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
10/29/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/18/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/21/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/06/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/19/2020
FIMP
FINAL DISPOSITION PROCESSED
02/19/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/29/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
10/29/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/13/2019
PUBO
PUBLISHED FOR OPPOSITION
08/13/2019
GPNX
NOTIFICATION PROCESSED BY IB
08/09/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/24/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/24/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/24/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/09/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/08/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/08/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
07/08/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/15/2019
GNFR
FINAL REFUSAL E-MAILED
01/15/2019
CNFR
FINAL REFUSAL WRITTEN
01/15/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/22/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/22/2018
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/22/2018
ALIE
ASSIGNED TO LIE
12/22/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/19/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/19/2018
RFNT
REFUSAL PROCESSED BY IB
09/01/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/13/2018
RFRR
REFUSAL PROCESSED BY MPU
08/13/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/31/2018
CNRT
NON-FINAL ACTION WRITTEN
07/30/2018
MAFR
APPLICATION FILING RECEIPT MAILED
07/27/2018
DOCK
ASSIGNED TO EXAMINER
07/23/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/23/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/19/2018
Continuous trademark protection
Get notified about every new filing that threatens INNOPHLEX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.